[ad_1]
The researchers found that the group receiving colchicine had an improvement in the insulin resistance test, which estimated the amount of insulin needed to maintain a normal blood sugar level compared to the placebo group.
The first group also recorded a reduction of the interactive protein blood test and other tests indicating an increase in the level of inflammation in the body due to obesity and playing a role in the development of type II diabetes compared with in the second group.
The drug "colchicine" inhibits a complex protein called "NLRP3" and causes inflammation that appears in obese people.
He added that "the study has proven that this drug protects against the complications associated with metabolic syndrome, which increases the risk of type II diabetes".
According to the World Health Organization, hyperactivity and physical inactivity are the cause of type 2 diabetes. In the long term, high blood sugar levels can increase the risk of heart disease, blindness, neurology and diabetes. 'renal failure.
Source link
